Annual General Meeting of SKAN Group AG approves all pro-posals and elects
Beat Lüthi as Chairman

SKAN AG / Key word(s): AGMEGM
Annual General Meeting of SKAN Group AG approves all pro-posals and elects
Beat Lüthi as Chairman

07.05.2024 / 18:00 CET/CEST

---------------------------------------------------------------------------

Media Information

Annual General Meeting of SKAN Group AG approves all proposals and elects
Beat Lüthi as Chairman

Allschwil, 7 May 2024 - The Annual General Meeting of SKAN Group AG was held
today in Allschwil. At the General Meeting a total of 91.59% of the share
capital entitled to vote was represented.

The Annual General Meeting approved all proposals of the Board of Directors.
In particular, it approved the distribution of CHF 0.35 per dividend-bearing
share, consisting of an ordinary dividend of CHF 0.175 per share and a
withholding tax-free distribution from capital reserves of CHF 0.175 per
share. The distribution will be made as from 14 May 2024.

The Board members standing for re-election Oliver Baumann, Cornelia Gehrig,
Thomas Huber, Beat Lüthi, Gregor Plattner and Patrick Schär have been
confirmed for another one-year term. Beat Lüthi was elected as new Chairman
of the Board of Directors.

The consultative votes on the remuneration report and the report on
non-financial matters were also approved.

The next Annual General Meeting of SKAN Group AG will take place on 5 May
2025.


Contacts:

Thomas Balmer, ir@skan.com, +41 79 703 87 28
Alexandre Müller, ir@skan.com, +41 79 635 64 13


Financial calendar:

     20 August 2024    Publication of the half-year results 2024
      25 March 2025              Publication Annual Results 2024
         5 May 2025                  Annual General Meeting 2025

SKAN - together always one step ahead

SKAN is a pioneer in the field of aseptic and aseptic-toxic manufacturing
processes for the (bio)pharmaceutical industry. The company is the market
and technology leader for high-quality, process-critical isolator systems
for filling drugs according to strict sterility standards. In addition, the
company offers its customers process support, services and consumables.
Innovative solutions and an efficient life-cycle support organisation make
SKAN an important partner for the pharmaceutical and biotech industry, CMOs
(Contract Manufacturing Organisations) and research laboratories worldwide.
Founded in 1968, SKAN today employs approximately 1400 people. More than
half of them work at the Allschwil headquarters in the Life Sciences Hub of
the Basel region. The other employees are located among the subsidiaries in
Switzerland, Germany, Belgium, Japan and the USA.


---------------------------------------------------------------------------

End of Media Release

---------------------------------------------------------------------------

   Language:       English
   Company:        SKAN AG
                   Kreuzstrasse 5
                   4123 Allschwil
                   Switzerland
   Phone:          +41 43 268 32 32
   E-mail:         info@skan.com
   ISIN:           CH0013396012
   Valor:          1339601
   Listed:         SIX Swiss Exchange
   EQS News ID:    1897861

End of News EQS News Service
---------------------------------------------------------------------------

1897861 07.05.2024 CET/CEST